Background Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a
serious threat to global efforts to combat tuberculosis. Inconsistent findings on the …

As we move into the era of the Sustainable Development Goals (SDGs), the World Health
Organization (WHO) has developed the End TB strategy 2016–2035 with a goal to end the …

Background Multidrug resistant (MDR) tuberculosis (TB) represents TB which is
simultaneous resistant to at least rifampicin (R) and isoniazid (H). Identifying inadequate …

Background Tuberculosis (TB) is a major public health problem in Bhutan despite the
implementation of directly observed treatment short-course since 1997. This study aimed to …

OBJECTIVES The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major
challenge for the global control of tuberculosis (TB). The aim of this study was to determine …

Background Tuberculosis (TB) is among the top 10 causes of mortality and the first killer
among infectious diseases worldwide. One of the factors fuelling the TB epidemic is the …

Introduction This study used Targeted Maximum Likelihood Estimation (TMLE) as a double
robust method to estimate the causal effect of previous tuberculosis treatment history on the …

SETTING: National Institute of Diseases of the Chest and Hospital, Dhaka; Bangladesh
Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders …

Background: An understanding of the patterns of drug-resistant tuberculosis (DR-TB) is
needed to develop the best diagnostic tools and decide on optimal treatment combination …

Methods: A retrospective record-based study (2009-2014) was conducted in three major
drug resistance TB treatment centres of Delhi. Treatment outcomes and adverse effects were …